Markets
← Back to Stocks
HSIC
HENRY SCHEIN INC
Health Care · Health Care Distributors
$72.68
-0.55%
Vol: 0.1M
Araverus Market Read
Thursday, March 19, 2026
Henry Schein down 0.58% pre-market despite 13.1% YoY Q3 earnings growth and 2026 ethical recognition.
Henry Schein declined 0.58% pre-market to $77.28 USD, moderating Q3 adjusted earnings of $1.38 (up 13.1% YoY, beating $1.28 consensus) and record $3.44B revenue (up 7.7% YoY). The company was again named 2026 World Most Ethical Company for 15th consecutive year, though analysts express caution over valuation and growth trajectory. Pre-market weakness suggests investors focused on near-term guidance concerns.
Price 50d 200d
Previous Market Reads
2 of 2 days↑
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$8.6B
P/E (TTM)22.2
Forward P/E12.4
Beta0.85
Div Yield—
Prev Close$73.08
RSI (14-Day)
14Oversold
0305070100
52-Week Range
$60.56$72.68$89.29
From High-18.6%
From Low+20.0%
Moving Averages
50d SMA
$77.81-6.6%
200d SMA
$72.08+0.8%
Price between 50d and 200d. Testing 50d support.
Returns
1W
-3.1%
1M
-6.9%
3M
-5.7%
6M
+7.9%
1Y
+0.9%
YTD
-5.4%
Volume
Today56K
20d Avg1.7M
Ratio0.03x